Therefore we examined the impact of inhibiting glycolysis or respiration in isogenic derivatives of the UM-SCC 1 line that express different mutations of TP53 which occur frequently in SCCHN, two structural mutants R175H and C176F and a contact mutant R282W [39]. Here, TP53 is linked to head and neck squamous cell carcinoma.